Advisor Group Holdings, Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History

Advisor Group Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$16.88 - $20.33 $8,828 - $10,632	523 Added 523.0%	623 $11,000
Q1 2024 May 10, 2024	SELL	$17.63 - $21.74 $16,677 - $20,566	-946 Reduced 90.44%	100 $1,000
Q4 2023 Feb 12, 2024	SELL	$14.37 - $19.07 $3,635 - $4,824	-253 Reduced 19.48%	1,046 $18,000
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $4,290 - $6,363	315 Added 32.01%	1,299 $22,000
Q1 2023 May 12, 2023	BUY	$10.7 - $15.79 $9,458 - $13,958	884 Added 884.0%	984 $10,000
Q1 2022 May 04, 2022	SELL	$9.3 - $12.37 $1,571 - $2,090	-169 Reduced 62.83%	100 $1,000
Q3 2021 Nov 05, 2021	BUY	$11.39 - $16.23 $227 - $324	20 Added 8.03%	269 $3,000
Q1 2021 May 13, 2021	BUY	$16.68 - $23.97 $4,153 - $5,968	249 New	249 $5,000
Q2 2020 Aug 14, 2020	SELL	$15.08 - $26.0 $1,508 - $2,600	-100 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$11.0 - $19.76 $1,100 - $1,976	100 New	100 $2,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $710M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.